Abstract
Five patients with adult-onset metachromatic leukodystrophy (MLD) underwent allo-SCT. Conditioning was reduced in intensity and grafts were obtained from voluntary unrelated donors. All but one graft were depleted of T-lymphocytes. Patient age at transplantation varied from 18 to 29 (median, 27) years. Two patients rejected their graft and MLD progressed. The recipient of the unmanipulated graft converted to complete donor chimerism with normalization of arylsulphatase A (ARSA) levels. Despite ARSA normalization, he deteriorated. Another patient was a mixed chimera. Following escalated doses of donor lymphocyte infusions he converted to complete donor chimerism. His levels of ARSA correlated positively with the percentage of donor cells and MLD was not progressive. The fifth patient died after 35 days from complications associated with GVHD. We conclude that results of allo-SCT in symptomatic MLD patients are poor. However, allo-SCT may stop progression of MLD in selected patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Figura von K, Gieselmann, Jaeken J . Metachromatic leukodystrophy. In: Schriver C, Beaudet A, Sly W, Valle D, (eds). The Metabolic and Molecular bases of inherited disease 8 ed McGraw-Hill: New York, 2001, pp 3695–3724.
Hyde TM, Ziegler JC, Weinberger DR . Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol 1992; 49: 401–406.
Hageman AT, Gabreels FJ, de Jong JG, Gabreels-Festen AA, van den Berg CJ, van Oost BA et al. Clinical symptoms of adult metachromatic leukodystrophy and arylsulfatase A pseudodeficiency. Arch Neurol 1995; 52: 408–413.
Prasad VK, Kurtzberg J . Transplant outcomes in mucopolysaccharidoses. Semin Hematol 2010; 47: 59–69.
Sevin C, Aubourg P, Cartier N . Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J Inherit Metab Dis 2007; 30: 175–183.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Maas F, Schaap N, Kolen S, Zoetbrood A, Buno I, Dolstra H et al. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 2003; 17: 621–629.
Fernandes J, Saudubray J, van den Gerghe G . Inborn metabolic diseases: diagnosis and treatment. 2nd ed Springer-Verlag: Berlin New York, 1995.
Hamilton R, Hamilton S . Lipid analysis. IRL press at Oxford University Press: Oxford, New York, 1992.
Innis MA, Gelfand DH, Sninsky JJ, White TJ . PCR Protocols. A Guide to Methods and Applications. Academic Press: San Diego, 1990.
D′Olhaberriague L, Litvan I, Mitsias P, Mansbach HH . A reappraisal of reliability and validity studies in stroke. Stroke 1996; 27: 2331–2336.
Kasner SE . Clinical interpretation and use of stroke scales. Lancet Neurol 2006; 5: 603–612.
Mahoney F, Barthel D . Functional evaluation: The barthel index. Md State Med J 1965; 14: 61–65.
Wechsler D . WAIS-R manual. Psychological Corporation 1981.
Ryan JJ, Schnakenberg-Ott SD . Scoring reliability on the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). Assessment 2003; 10: 151–159.
Kamphuis G . A study on the reliability of the Bourdon Wiersma test. Ned Tijdschr Psychol 1962; 17: 269–275.
Luteijn F . A new abbreviated groninger intelligence test. Ned Tijdschr Psychol 1966; 21: 675–682.
Wechsler D . Wechsler memory scale-revised. Psychological Corporation 1987.
Grewel F . The Bourdon–Wiersma test. Folia Psychiatr Neurol Neurochir Neerl 1953; 56: 694–703.
Demaerel P, Faubert C, Wilms G, Casaer P, Piepgras U, Baert AL . MR findings in leukodystrophy. Neuroradiology 1991; 33: 368–371.
Franssen H, van den Bergh PY . Nerve conduction studies in polyneuropathy: practical physiology and patterns of abnormality. Acta Neurol Belg 2006; 106: 73–81.
Kowalski JW, Rasheva M, Zakrzewska B . Visual and brainstem auditory evoked potentials in hereditary motor-sensory neuropathy. Electromyogr Clin Neurophysiol 1991; 31: 167–172.
Biffi A, Lucchini G, Rovelli A, Sessa M . Metachromatic leukodystrophy: an overview of current and prospective treatments. Bone Marrow Transplant 2008; 42 (Suppl 2): S2–S6.
Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG . The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 1995; 18: 398–412.
Solders G, Celsing G, Hagenfeldt L, Ljungman P, Isberg B, Ringden O . Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy. Bone Marrow Transplant 1998; 22: 1119–1122.
Shapiro EG, Lockman LA, Balthazor M, Krivit W . Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995; 18: 413–429.
Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W . Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215–222.
Meuleman N, Vanhaelen G, Tondreau T, Lewalle P, Kwan J, Bennani J et al. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica 2008; 93: e11–e13.
Tylki-Szymanska A, Lugowska A, Chmielik J, Kotowicz J, Jakubowska-Winecka A, Zobel M et al. Investigations of micro-organic brain damage (MOBD) in heterozygotes of metachromatic leukodystrophy. Am J Med Genet 2002; 110: 315–319.
Molzer B, Sundt-Heller R, Kainz-Korschinsky M, Zobel M . Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity. Am J Med Genet 1992; 44: 523–526.
Church H, Tylee K, Cooper A, Thornley M, Mercer J, Wraith E et al. Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease. Bone Marrow Transplant 2007; 39: 207–210.
Mattsson J, Ringden O, Storb R . Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14 (1 Suppl 1): 165–170.
Boelens JJ, Wynn RF, O′Meara A, Veys P, Bertrand Y, Souillet G et al. Outcomes of hematopoietic stem cell transplantation for Hurler′s syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225–233.
Malm G, Ringden O, Winiarski J, Grondahl E, Uyebrant P, Eriksson U et al. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1003–1008.
Escolar ML, Poe MD, Martin HR, Kurtzberg J . A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation. Pediatrics 2006; 118: e879–e889.
Peters C, Steward CG . Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 2003; 31: 229–239.
Colle MA, Piguet F, Bertrand L, Raoul S, Bieche I, Dubreil L et al. Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate. Hum Mol Genet 2010; 19: 147–158.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
de Hosson, L., van de Warrenburg, B., Preijers, F. et al. Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature. Bone Marrow Transplant 46, 1071–1076 (2011). https://doi.org/10.1038/bmt.2010.252
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.252
Keywords
This article is cited by
-
S1-Leitlinie: Leukodystrophien und hereditäre Leukenzephalopathien im Erwachsenenalter
DGNeurologie (2023)
-
Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy
Molecular and Cellular Pediatrics (2020)
-
Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
Orphanet Journal of Rare Diseases (2019)
-
Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report
Orphanet Journal of Rare Diseases (2015)
-
Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy
Bone Marrow Transplantation (2014)